Share Issue/Capital Change • Jun 19, 2024
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
Borregaard ASA: Borregaard invests further into Alginor
Borregaard has participated with its fully diluted pro-rata share (35%) in the
NOK 400 million capital raise in the marine biotech company Alginor to fund the
next step of the biorefinery expansion. The funds from Borregaard were pre-
committed. In aggregate the committed investments into Alginor from Borregaard
will now total approximately NOK 408 million.
Alginor intends to carry out a repair offering directed towards existing
shareholders and potential new shareholders. A subsequent offering towards
Borregaard will be made to ensure that Borregaard retains its 35% fully diluted
ownership in Alginor.
For more information about Alginor and the capital raise,
see?https://alginor.no/.
?
Contact:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.